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Around 50-60% of all cancer patients undergo radiation therapy. Although some patients show 
complete response with no recurrence, a significant proportion of the population still develop 
radiation resistance. It is important to identify tumor resistance at early stages of therapy in order 
to adjust treatment protocol and avoid extra exposure to radiation. Current methods to assess 
treatment response are only limited to anatomical measurements of tumor volume after therapy. 
Novel approaches that shed the light on any functional information during the course of 
radiotherapy could significantly improve our ability to identify patients who do not respond to 
radiation therapy. Diffuse reflectance spectroscopy (DRS) is an optical fiber-based technique that 
is capable of quantitative, nondestructive, and repeated measurements of tumor biology. Our aim 
was to determine the sensitivity of DRS to escalating doses of radiation. An additional goal was to 
determine DNA damage and changes in hypoxic fraction post-radiation, and to determine if these 
immunohistochemical assessments were concordant with changes in optical properties, such as 
tissue scattering, hemoglobin concentration, and vascular oxygenation. Lookup table (LUT)-based 
model was used to fit the acquired DRS spectra and extract wavelength-dependent absorption and 
scattering properties from tissue. Our results have shown that the measurements of tumor optical 
properties such as oxygen saturation and total hemoglobin can provide reliable estimates of the 
hypoxic state of tissue. Additionally, we present significant increase in hypoxic fraction between 
control and irradiated groups. 
 
Introduction  
According to the American Cancer Society, about 268,600 new cases of invasive breast cancer 
will be diagnosed in 2019. Radiation therapy is usually recommended after lumpectomy because 
it lowers the risk of breast cancer recurrence1. Radiation therapy destroys cancerous cells by 
depositing high-energy rays of photons (X-rays and gamma) or particles such as protons, neutrons 
and alpha2. Radiation is commonly delivered through two mechanisms: externally using an outside 
source such as cathode ray tubes, linear accelerator or cobalt machines (external beam radiation), 
or internally by radioactive source inside the body using catheters or seeds (brachytherapy)3.  
 
The overall outcome of radiation therapy is to cause functional abnormalities within the cell 
through direct and indirect actions, which eventually kills tumor cells over weeks of treatment. 
Presence of oxygen within cancerous cells is important to damage DNA and other macromolecules 
which are essential for cell survival. Tumor cells have developed multiple strategies to resist 
radiation damage. For instance, Hypoxia (𝑝𝑂2< 10 mg/Hg) significantly affects the outcome of 
radiation treatment and is associated with poor survival rates in cancer patient. Therefore, tumor 
hypoxia has been studied as a potential marker of developing resistance to radiation therapy3.  
 
At this moment, there is no accepted technique that would enable early detection of radiation 
resistant tumors. Currently, imaging method used for assessing response to therapy such as 
Positron Emission Tomography (PET) imaging of 18 F- Flurorodeoxy glucose (FDG) uptake or 
MRI are expensive and does not allow repeated measurements4. Moreover, PET imaging can be 
used only 5 or 6 weeks after therapy due to the limitation of radiolabeled isotope. Therefore, there 
 
is an urgent clinical need for a viable technique that identify patients having poor response to 
radiation therapy on the early stage of the treatment5.  
 
Current methods for measuring oxygen level within tissue are oxygen 𝑝𝑂2microelectrodes, blood 
oxygen level dependent (BOLD) Magnetic resonance imaging (MRI), dynamic contrast enhanced 
(DCE)-MRI, PET imaging [18F]-labeled fluoromisonidazole (FMISO). The limitations of these 
current techniques are invasiveness level, ability for frequent measurements, and indirect 
assessment of tissue oxygen status. 𝑝𝑂2microelectrodes are invasive, not capable of repeated 
clinical measurements, and measures hypoxia over a limited area of the tissue. Both MRI 
techniques provide indirect assessment of tissue oxygen level. Due to accumulation of FMISO 
contrast agent in normal tissue, this technique cannot be repeated frequently6. In contrast, diffuse 
reflectance spectroscopy (DRS) is an optical fiber technique which provides quantitative, non-
destructive, and repeated measurements of tissue vascular oxygenation based on hemoglobin 
absorption7. 
 
In DRS, light is generated by a halogen lamp light source and sent to the tissue through optical 
fiber probe. Fiber probe send the light from the source to the tissue and collect the reflected light 
back from tissue. The separation between the source and detector optical fibers determine the 
sampling depth. From the reflected light, tissue optical properties such as scattering, and 
absorption can be measured. The main tissue components that contribute to absorption are melanin 
in epidermis and hemoglobin located in blood vessels in the dermis.  There are two types of 
hemoglobin in blood: hemoglobin bound to oxygen (oxygenated 𝐻𝑏𝑂2),and unbound hemoglobin 
(deoxygenated dHb). Based on Figure 1, oxygenated and deoxygenated hemoglobin have 
 
distinguishable absorption spectra over a wavelength range of 500-600 nm. Oxygenated 
hemoglobin has double peaks at 542 and 577 nm, while deoxygenated hemoglobin has a single 
peak at 560 nm8.  
 
Figure 1: Absorption spectra of tissue components mainly contributing to the absorption of light 
in the range of 300-1000 nm: oxygenated hemoglobin(𝐻𝑏𝑂2), deoxygenated hemoglobin(dHb). 
 
The vascular oxygenation (𝑆𝑂2)can be quantified by calculating the ratio between oxygenated 
and total hemoglobin concentration as shown in equation 1: 
𝑆𝑂2 =  
𝐻𝑏𝑂2
𝐻𝑏𝑂2+𝑑𝐻𝑏
× 100%    equ.(1) 
Absorption is described using an absorption coefficient 𝜇𝑎(𝜆) as the following: 
𝜇𝑎(𝜆) =  [𝑐𝐻𝑏] [𝛼 𝜀𝐻𝑏𝑂2(𝜆) + (1 − 𝛼)𝜀𝑑𝐻𝑏(𝜆)] +  𝜀𝑚𝑒𝑙(𝜆)𝑐𝑚𝑒𝑙   equ. (2) 
Where 𝑐𝐻𝑏 is total hemoglobin concentration, 𝛼 is oxygen saturation, 
𝜀𝐻𝑏𝑂2(𝜆), 𝜀𝑑𝐻𝑏(𝜆),  𝜀𝑚𝑒𝑙(𝜆) are the molar extinction coefficients of oxygenated hemoglobin, 
 
deoxygenated hemoglobin and melanin, respectively. Similarly, scattering due to collagen, 
mitochondria, and nuclei can be described by scattering coefficient 𝜇𝑠
′ (𝜆)as given in equation 3: 
𝜇𝑠
′ (𝜆) = 𝜇𝑠
′ (𝜆) + (
𝜆
𝜆0
)−𝐵   equ.(3) 
Where 𝜆0 =  630 𝑛𝑚, and B is the scattering power related to scattering particle size. 
Consequently, reflectance is calculated as the ratio between the intensity of reflected light to that 
of the incident light 9. DRS accuracy and sensitivity are mainly dependent on two factors: fiber 
optic probe source-detector separation, and lookup table LUT- based inverse model to extract 
optical parameters10. 
 
The goal of this study is to determine the sensitivity of DRS to change in tumor oxygenation 
immediately after radiation. To achieve this goal, three aims were established: 
1. Determine dose-dependent changes in tumor oxygenation using escalating doses of 
radiation (2Gy, 8Gy). 
2. Determine depth-dependent radiation response using fiber optic probes with different 
source-detector separations. 
3. Determine the correlation between immunohistochemical assessment of hypoxia and DRS 







Cell Culture and Tumor Xenograft  
All studies and protocols were approved by the Institutional Animal Care & Use Committee 
(IACUC) of the University of Arkansas. Twenty-one balb/c mice were kept under standard 12 
hours light and dark cycles at the Central Laboratory Animal Facility (CLAF). 4T1 murine 
mammary adenocarcinoma cells were injected into the mice (500,000 cells in 100 μl) to grow 
subcutaneous tumor xenografts. When the tumor volume reached 200 𝑚𝑚3, DRS measurements 
were acquired on all mice. Tumors were excised from 5 mice in the control group. The other 16 
mice were distributed into two groups to undergo radiation of 2 Gy (n = 10) and 8 Gy (n=6), 
respectively. Immediately after radiation, DRS spectra were recorded and mice were injected with 
pimonidazole, an established hypoxia marker (60 mg/kg, solution of 12 mg/ml). About 60 minutes 
post-injection, tumors were excised and snap-frozen in OCT compound.  
 
Quantification of tissue optical properties  
DRS consists of halogen lamp (HL-2000, Ocean Optics, Dunedin, Florida) as a light source, a 
USB spectrometer (Flame, Ocean Optics) for acquisition, and a fiber optic probe of source-detector 
separation of 1.5 mm and 2.25 mm as shown in figure 2. An established lookup table-based model 
(LUT) was used to quantify optical properties of tumor such as vascular oxygenation, hemoglobin 
concentration, and tissue scattering.  
 
    
Figure 2: (A) Experimental setup of DRS and (B) bifurcated fiber optic probe illustrating the 
common tissue end, the source end that is connected to the light source, and the detector end that 
is connected to the USB spectrometer.  
 
Immunohistochemical Assessment  
Frozen tumors were stored -80 C and were sliced into sections of 10 μm using a cryotome (CM 
1850; leica, Inc., Nussloch, Germany). Based on the source-detector separation of 1.5 and 2.25 
mm, tumor slices were obtained at depth ranges of (0.8-1.2 mm) and (1.4-1.8 mm), respectively. 
Direct labeling protocol was followed to stain with antibodies targeted to pimonidazole. First, 
slices were fixed with 4 % PFA, washed for three times with PBS (3 seconds each), and 
permeabilized with 0.1% Triton-X. Next, it was washed and incubated with blocking solution 
(95% PBS, 4% goat serum, and 1% sodium azide) for an hour in room temperature. Then, it was 
stained with primary antibody (Hypoxyprobe Red549 kit; HPI, Inc., Burlington, Massachusetts) 
for an hour in a dark room. After rinsing with PBS, slides were covered with fluoromount and 




Image and statistical Analysis  
MATLAB (Mathworks; Natick, Massachusetts) was used to analyze immunofluorescence images 
at the specified depth ranges. First, each single image was converted into a grayscale image to find 
the local threshold using Otsu’s method11. Then, global threshold was calculated. Hypoxic fraction 
was computed by finding the ratio of segmented pixels (hypoxic) to the total pixels in tissue. All 
statistical analysis was performed using JMP (SAS, Cary, NC). Two-way ANOVA test was 
utilized to determine changes in hypoxic fraction of the three groups of interest at different depths. 
Linear correlation test was conducted to determine the relation between the optical properties and 












Results & Discussion 
Figure 3a presents DRS spectra from control, 2 Gy, and 8 Gy groups which were collected when 
tumor volume reached 200 𝑚𝑚3. Similarly, Figure 3b presents wavelength-dependent absorption 
coefficient extracted from LUT model fit to DRS spectra. Our findings show the double peaks of 
at 542 and 577 nm appear less prominent in irradiated groups of 2 Gy and 8 Gy, which indicates 
lower levels of vascular oxygenation.  
 
 
Figure 3: (A) Representation in vivo DRS spectra and their LUT fits from control, 2Gy, 8Gy 
groups at V=200 𝑚𝑚3. (B) Corresponding wavelength-dependent absorption coefficients 
determined from LUT fits to spectra.  
 
Figure 4 represents the immunohistochemical images of hypoxic fraction in all of the three groups 
of interest at different depth ranges. Our results have shown an increasing trend in hypoxic fraction 
in response to radiation. We also investigated depth-dependent changes in hypoxia, but there was 
not a significant relation between HF and depth.  
 
  
Figure 4: Pimonidazole immunofluorescence image of (A) control with HF= 4.66%, (B) 2Gy 
with HF= 14.67%, (C) 8Gy with HF= 21.95%. (D) Fold-change in hypoxia level of control, 2Gy, 
and 8Gy group with depth of (0.8-1.2 mm, and 1.4-1.8 mm). Error bars represent standard 
deviation. * represents p value <=0.05 
 
Figure 5 presents the changes of oxygen saturation among the three groups of interests at depth 
range of (0.8-1.2 mm) and (1.4-1.8 mm). Our findings show decreasing trend in oxygenation at 




Figure 5: Shows mean values of oxygen saturation sO2 (%) of control, 2Gy, 8Gy groups, 
collected at source-detector separation of 1.5 and 2.25 mm. Error bars represent SEM.  
 
Based on pimonidazole bound areas in tissue and vascular oxygen saturation detected with 
quantitative optical Diffuse Reflectance Spectroscopy (DRS), a statistically significant negative 
correlation was found between hypoxic fraction and vascular oxygenation as shown in figure 6. 
Tumors with high oxygen saturation represents low hypoxic fraction and vice versa. These 
findings support that vascular oxygenation measured using DRS are concordant with hypoxic 
fraction and can be used as indirect indication of tumor oxygenation, which is consistent with 
previous findings in a similar xenograft model9.  
 
 
Figure 6:  scatterplot representing the relationship between HF measure at depth of (0.8-1.2 mm) 
and DRS-based measures of sO2 (%) collected at SD=1.5mm. Black solid line indicate 
regression line with p=0.0395, R2=0.226. 
Our future work includes plans to study time-dependent changes in tumor microenvironment in 
response to escalating doses of radiation. Hypoxic fraction increases after the exposure to 
radiation, we are currently investigating the mechanism behind this increase in hypoxia. 
Conclusion 
Radiation therapy has shown to be highly cost effective with a single modality treatment and 
accounts for about 5% of the total cost of cancer treatments. As a result, any improvement in 
radiation therapy efficiency will benefit a significant number of cancer patients. One of the main 
challenges in the modern oncology is tumor resistance against radiation treatment. DRS is a 
potential technique that may be used in assessing tumor response to radiation therapy at early 
stages of the treatment. In this study, we found that there were no significant depth-dependent 
changes in oxygen saturation or hypoxic fraction levels has been observed. However, there was 
 
significant change in hypoxia in irritated groups of 2 Gy and 8 Gy. Monitoring vascular oxygenation 
can provide clinical assessment of tumor microenvironment during the course of the treatment.  
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